Senseonics Holdings, Inc.
$6.87
▲
3.76%
2026-04-21 09:21:01
www.senseonics.com
NMS: SENS
Explore Senseonics Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$287.13 M
Current Price
$6.87
52W High / Low
$15.74 / $5.25
Stock P/E
—
Book Value
$1.48
Dividend Yield
—
ROCE
-67.05%
ROE
-1.68%
Face Value
—
EPS
$-1.66
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
130
Beta
1.05
Debt / Equity
67.77
Current Ratio
4.83
Quick Ratio
4.55
Forward P/E
-2.54
Price / Sales
7.92
Enterprise Value
$226.37 M
EV / EBITDA
-3.39
EV / Revenue
6.42
Rating
None
Target Price
$18.92
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 2. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 3. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
| 4. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 5. | Baird Medical Investment Holdings Limited | $1.79 | 55.75 | $64.64 M | — | 35.34% | -8.03% | $7.26 / $0.76 | $1.34 |
| 6. | Elutia Inc. | $1.12 | 0.92 | $49.2 M | — | -49.48% | -574.35% | $2.64 / $0.5 | $0.65 |
| 7. | AVITA Medical, Inc. | $5 | — | $157.45 M | — | 676.75% | 799.72% | $10.29 / $3.22 | $-0.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 14.26 M | 8.1 M | 6.65 M | 6.26 M | 8.3 M | — |
| Operating Profit | -20.93 M | -19.6 M | -14.32 M | -13.49 M | -14.27 M | — |
| Net Profit | -20.82 M | -19.53 M | -14.5 M | -14.26 M | -15.48 M | — |
| EPS in Rs | -0.5 | -0.47 | -0.35 | -0.34 | -0.37 | -0.8 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 35.26 M | 22.47 M | 22.39 M | 16.39 M |
| Operating Profit | -68.34 M | -74.84 M | -75.6 M | -68.63 M |
| Net Profit | -69.11 M | -78.62 M | -60.39 M | 142.12 M |
| EPS in Rs | -1.65 | -1.88 | -1.44 | 3.4 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 126.27 M | 100.44 M | 138.22 M | 177.67 M |
| Total Liabilities | 65.22 M | 116.99 M | 102.42 M | 180.25 M |
| Equity | 61.05 M | -16.55 M | 35.8 M | -2.58 M |
| Current Assets | 117.53 M | 91.44 M | 130.03 M | 161.2 M |
| Current Liabilities | 24.35 M | 38.85 M | 17.26 M | 31.47 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -59.13 M | -60.47 M | -70.16 M | -66.31 M |
| Investing CF | -53.42 M | 32.84 M | 89.71 M | 26.88 M |
| Financing CF | 78.19 M | 26.83 M | 20.37 M | 41.76 M |
| Free CF | -60.24 M | -62.7 M | -70.51 M | -66.62 M |
| Capex | -1.12 M | -2.24 M | -0.35 M | -0.31 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.37% | 36.62% | — | — |
| Earnings Growth % | -30.18% | -142.49% | — | — |
| Profit Margin % | -349.84% | -269.73% | 867.16% | — |
| Operating Margin % | -333.05% | -337.66% | -418.74% | — |
| Gross Margin % | 2.37% | 13.81% | 16.63% | — |
| EBITDA Margin % | -305.73% | -214.4% | 987.29% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-10-20 | 1:0.05 |